Thyroid Dysfunction from Antineoplastic Agents

Por Hamnvik, Ole-Petter Riksfjord, Larsen, P. Reed, Marqusee, Ellen
Publicado em 2011

Optimizing bone health in anorexia nervosa and hypothalamic amenorrhea: new trials and tribulations

Por Foo, Joo-Pin, Hamnvik, Ole-Petter R., Mantzoros, Christos S.
Publicado no Metabolism (2012)

Leptin as a Modulator of Neuroendocrine Function in Humans

Por Khan, Sami M., Hamnvik, Ole-Petter R., Brinkoetter, Mary, Mantzoros, Christos S.
Publicado em 2012

Omentin-1 levels are reduced by pharmacologic doses of leptin, but remain unaffected by energy deprivation and display no day-night variation

Por Hamnvik, Ole-Petter Riksfjord, Thakkar, Bindiya, Chamberland, John, Aronis, Konstantinos, Schneider, Benjamin, Mantzoros, Christos S.
Publicado no Int J Obes (Lond) (2014)

Differential Effects of Oral and Intravenous Lipid Administration on Key Molecules Related to Energy Homeostasis

Por Vamvini, Maria T., Hamnvik, Ole-Petter, Sahin-Efe, Ayse, Gavrieli, Anna, Dincer, Fadime, Farr, Olivia M., Mantzoros, Christos S.
Publicado no J Clin Endocrinol Metab (2016)

Adiponectin administration prevents weight gain and glycemic profile changes in diet-induced obese immune deficient Rag1−/− mice lacking mature lymphocytes

Por Liu, Xiaowen, Perakakis, Nikolaos, Gong, Huizhi, Chamberland, John P., Brinkoetter, Mary T., Hamnvik, Ole-Petter R, Mantzoros, Christos S.
Publicado no Metabolism (2016)

Leptin in human physiology and pathophysiology

Por Mantzoros, Christos S., Magkos, Faidon, Brinkoetter, Mary, Sienkiewicz, Elizabeth, Dardeno, Tina A., Kim, Sang-Yong, Hamnvik, Ole-Petter R., Koniaris, Anastasia
Publicado em 2011

Leptin's Role in Lipodystrophic and Nonlipodystrophic Insulin-Resistant and Diabetic Individuals

Por Moon, Hyun-Seuk, Dalamaga, Maria, Kim, Sang-Yong, Polyzos, Stergios A., Hamnvik, Ole-Petter, Magkos, Faidon, Paruthi, Jason, Mantzoros, Christos S.
Publicado em 2013

Gender Dimorphism and Energy Deprivation on Undercarboxylated Osteocalcin Levels in Humans

Por Foo, Joo-Pin, Aronis, Konstantinos N., Chamberland, John P., Thakkar, Bindiya, Hamnvik, Ole-Petter, Brinkoetter, Mary, Zaichenko, Lesya, Mantzoros, Christos S.
Publicado no Obesity (Silver Spring) (2013)

Clinical risk factors for the development of hypertension in patients treated with inhibitors of the VEGF signaling pathway

Por Hamnvik, Ole-Petter R., Choueiri, Toni K., Turchin, Alexander, McKay, Rana R., Goyal, Lipika, Davis, Michael, Kaymakcalan, Marina D., Williams, Jonathan S.
Publicado no Cancer (2014)

Circulating alanine transaminase (ALT) and γ-glutamyl transferase (GGT), but not fetuin-A, is associated with metabolic risk factors, at baseline and at two-year follow-up: the pro...

Por Liu, Xiaowen, Hamnvik, Ole-Petter R, Chamberland, John P, Petrou, Michael, Gong, Huizhi, Christophi, Costas A, Christiani, David C, Kales, Stefanos N, Mantzoros, Christos S
Publicado em 2014

Angiotensin system inhibitors and survival outcomes in patients with metastatic renal cell carcinoma

Por McKay, Rana R., Rodriguez, Gustavo E., Lin, Xun, Kaymakcalan, Marina D., Hamnvik, Ole-Petter R., Sabbisetti, Venkata S., Bhatt, Rupal S., Simantov, Ronit, Choueiri, Toni K.
Publicado no Clin Cancer Res (2015)